Physiological studies of stress responses in the hypothalamus of vasopressin-enhanced green fluorescent protein transgenic rat

Journal of Neuroendocrinology

Volumn 19, Issue 4, 2007, Pages 285-292

  Shibata, M ^a   Fujihara, H ^a   Suzuki, H ^a   Ozawa, H ^b   Kawata, M ^c   Dayanithi, G ^d   Murphy, D ^e   Ueta, Y ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^d HÔPITAL SAINT ELOI   (France)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Adrenalectomy; GFP; Lipopolysaccharide; Paraventricular nucleus; Vasopressin

Indexed keywords

ARGIPRESSIN; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; GLUCOCORTICOID; GREEN FLUORESCENT PROTEIN; LIPOPOLYSACCHARIDE;

ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR HYPOTHALAMUS; ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE ANALYSIS; HORMONE ACTION; HORMONE RESPONSE; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOREACTIVITY; MAGNOCELLULAR NUCLEUS; MALE; MEDIAN EMINENCE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; STRESS; TRANSGENIC RAT;

ADRENALECTOMY; ANIMALS; ANIMALS, GENETICALLY MODIFIED; FEMALE; GLUCOCORTICOIDS; GREEN FLUORESCENT PROTEINS; HYPOTHALAMUS; INFLAMMATION; MALE; MODELS, ANIMAL; RATS; RATS, WISTAR; STRESS, PSYCHOLOGICAL; VASOPRESSINS;

EID: 33847716754     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2007.01532.x     Document Type: Article

References (37)

1. Aguilera G, Rabadan-Diehl C. Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: Implications for stress adaptation. Regul Pept 2000; 96: 23-29.
2. Aguilera G, Rabadan-Diehl C. Regulation of vasopressin V1b receptors in the anterior pituitary gland of the rat. Exp Physiol 2000; 85: 19S-26S.
3. Antoni FA. Novel ligand specificity of pituitary vasopressin receptors in the rat. Neuroendocrinology 1984; 39: 186-188.
4. Jard S, Gaillard RC, Guillon G, Marie J, Schoenenberg P, Muller AF, Manning M, Sawyer WH. Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis. Mol Pharmacol 1986; 30: 171-177.
5. Sugimoto T, Saito M, Mochizuki S, Watanabe Y, Hashimoto S, Kawashima H. Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor. J Biol Chem 1994; 269: 27088-27092.
6. Swanson LW, Simmons DM. Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: A hybridization histochemical study in the rat. J Comp Neurol 1989; 285: 413-435.
7. Dayanithi G, Antoni FA. Rapid as well as delayed inhibitory effects of glucocorticoid hormones on pituitary adrenocorticotropic hormone release are mediated by type II glucocorticoid receptors and require newly synthesized messenger ribonucleic acid as well as protein. Endocrinology 1989; 125: 308-313.
8. Herman JP, Wiegand SJ, Watson SJ. Regulation of basal corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid expression in the paraventricular nucleus: Effects of selective hypothalamic deafferentations. Endocrinology 1990; 127: 2408-2417.
9. Link H, Dayanithi G, Gratzl M. Glucocorticoids rapidly inhibit oxytocin-stimulated adrenocorticotropin release from rat anterior pituitary cells, without modifying intracellular calcium transients. Endocrinology 1993; 132: 873-878.
10. Antoni FA. Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Front Neuroendocrinol 1993; 14: 76-122.
11. Kovacs KJ, Foldes A, Sawchenko PE. Glucocorticoid negative feedback selectively targets vasopressin transcription in parvocellular neurosecretory neurons. J Neurosci 2000; 20: 3843-3852.
12. Sawchenko PE, Swanson LW, Vale WW. Co-expression of corticotropin-releasing factor and vasopressin immunoreactivity in parvocellular neurosecretory neurons of the adrenalectomized rat. Proc Natl Acad Sci USA 1984; 81: 1883-1887.
13. Whitnall MH. Stress selectively activates the vasopressin-containing subset of corticotropin-releasing hormone neurons. Neuroendocrinology 1989; 50: 702-707.
14. Rivier C, Vale W. Interaction of corticotropin-releasing factor and arginine vasopressin on adrenocorticotropin secretion in vivo. Endocrinology 1983; 113: 939-942.
15. Gillies GE, Linton EA, Lowry PJ. Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature 1982; 299: 355-357.
16. Serradeil-Le Gal C, Wagnon J, Simiand J, Griebel G, Lacour C, Guillon G, Barberis C, Brossard G, Soubrie P, Nisato D, Pascal M, Pruss R, Scatton B, Maffrand JP, Le Fur G. Characterization of
17. Ueta Y, Fujihara H, Serino R, Dayanithi G, Ozawa H, Matsuda K, Kawata M, Yamada J, Ueno S, Fukuda A, Murphy D. Transgenic expression of enhanced green fluorescent protein enables direct visualization for physiological studies of vasopressin neurons and isolated nerve terminals of the rat. Endocrinology 2005; 146: 406-413.
18. Fujio T, Fujihara H, Shibata M, Yamada S, Onaka T, Tanaka K, Morita H, Dayanithi G, Kawata M, Murphy D, Ueta Y. Exaggerated response of arginine vasopressin-enhanced green fluorescent protein fusion gene to salt loading without disturbace of body fluid homeostasis in rats. J Neuroendocrinol 2006; 18: 776-785.
19. Nolan LA, Thomas CK, Levy A. Enhanced anterior pituitary mitotic response to adrenalectomy after multiple glucocorticoid exposures. Eur J Endocrinol 2003; 149: 153-160.
20. Saito J, Ozaki Y, Ohnishi H, Nakamura T, Ueta Y. Induction of galanin-like peptide gene expression in the rat posterior pituitary gland during endotoxin shock and adjuvant arthritis. Brain Res Mol Brain Res 2003; 113: 124-132.
21. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. San Diego, CA: Academic Press, 1994.
22. Kiss JZ, Mezey E, Skirboll L. Corticotropin-releasing factor-immunoreactive neurons of the paraventricular nucleus become vasopressin positive after adrenalectomy. Proc Natl Acad Sci USA 1984; 81: 1854-1858.
23. Ma XM, Levy A, Lightman SL. Rapid changes of heteronuclear RNA for arginine vasopressin but not for corticotropin releasing hormone in response to acute corticosterone administration. J Neuroendocrinol 1997; 9: 723-728.
24. Stillman MA, Recht LD, Rosario SL, Seif SM, Robinson AG, Zimmerman EA. The effects of adrenalectomy and glucocorticoid replacement on vasopressin and vasopressin-neurophysin in the zona externa of the median eminence of the rat. Endocrinology 1977; 101: 42-49.
25. Whitnall MH, Key S, Gainer H. Vasopressin-containing and vasopressin-deficient subpopulations of corticotropin-releasing factor axons are differentially affected by adrenalectomy. Endocrinology 1987; 120: 2180-2182.
26. Chisari AN, Perone MJ, Giovambattista A, Spinedi E. Gender-dependent characteristics of the hypothalamo-corticotrope axis function in glucocorticoid-replete and glucocorticoid-depleted rats. J Endocrinol Invest 1998; 21: 737-743.
27. Viau V, Chu A, Soriano L, Dallman MF. Independent and overlapping effects of corticosterone and testosterone on corticotropin-releasing hormone and arginine vasopressin mRNA expression in the paraventricular nucleus of the hypothalamus and stress-induced adrenocorticotropic hormone release. J Neurosci 1999; 19: 6684-6693.
28. Ferrini MG, Grillo CA, Piroli G, de Kloet ER, De Nicola AF. Sex difference in glucocorticoid regulation of vasopressin mRNA in the paraventricular hypothalamic nucleus. Cell Mol Neurobiol 1997; 17: 671-686.
29. Franco-Bourland RE. Vasopressinergic, oxytocinergic, and somatostatinergic neuronal activity after adrenalectomy and immobilization stress. Neurochem Res 1998; 23: 695-701.
30. Spinedi E, Giacomini M, Jacquier MC, Gaillard RC. Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: Evidence for a median eminence site of glucocorticoid action. Neuroendocrinology 1991; 53: 160-170.
31. Watts AG. Glucocorticoid regulation of peptide genes in neuroendocrine CRH neurons: A complexity beyond negative feedback. Front Neuroendocrinol 2005; 26: 109-130.
32. Lenczowski MJ, Van Dam AM, Poole S, Larrick JW, Tilders FJ. Role of circulating endotoxin and interleukin-6 in the ACTH and corticosterone response to intraperitoneal LPS. Am J Physiol 1997; 273: R1870-R1877.
33. Watanobe H, Yoneda M. A mechanism underlying the sexually dimorphic ACTH response to lipopolysaccharide in rats: Sex steroid modulation of cytokine binding sites in the hypothalamus. J Physiol 2003; 547: 221-232.
34. Rivest S, Laflamme N. Neuronal activity and neuropeptide gene transcription in the brains of immune-challenged rats. J Neuroendocrinol 1995; 7: 501-525.
35. Matsunaga W, Miyata S, Takamata A, Bun H, Nakashima T, Kiyohara T. LPS-induced Fos expression in oxytocin and vasopressin neurons of the rat hypothalamus. Brain Res 2000; 858: 9-18.
36. Xu S, Guo S, Jiang X, Yin Q, Umezawa T, Hisamitsu T. Effect of indomethacin on the c-fos expression in AVP and TH neurons in rat brain induced by lipopolysaccharide. Brain Res 2003; 966: 13-18.
37. Spinedi E, Suescun MO, Hadid R, Daneva T, Gaillard RC. Effects of gonadectomy and sex hormone therapy on the endotoxin-stimulated hypothalamo-pituitary-adrenal axis: Evidence for a neuroendocrine-immunological sexual dimorphism. Endocrinology 1992; 131: 2430-2436.